JENNIFER DOBROWOLSKI: Open Payments
NPI 1396218608 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,228 in 203 payments from 37 companies in 2025. Trend: 2023 $3,306 · 2024 $4,389 · 2025 $4,228
Food & beverage: $4,209Speaker / faculty: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $460 |
| ARGENX US, INC. | 13 | $363 |
| Eisai Inc. | 4 | $278 |
| PFIZER INC. | 13 | $211 |
| MDD US Operations, LLC | 10 | $195 |
| UCB, Inc. | 14 | $185 |
| JAZZ PHARMACEUTICALS INC. | 11 | $180 |
| EMD Serono, Inc. | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $171 |
| Vanda Pharmaceuticals Inc. | 8 | $165 |
Products named: VYVGART, Leqembi, QULIPTA, NURTEC ODT, EPIDIOLEX, HYQVIA, PONVORY, INGREZZA.
Industry payments across IN — which companies pay providers there.
